Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Letizia Gianoncelli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|April 23, 2025
Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future OutlookGiovanni Luca Ceresoli, Letizia Gianoncelli
Annals of Translational Medicine|May 21, 2015
Prognostic and predictive value of MET deregulation in non-small cell lung cancerGiovanna Finocchiaro, Luca Toschi, Letizia Gianoncelli, et al.
Cancer Treatment Reviews|November 3, 2009
Second-line treatment for malignant pleural mesotheliomaGiovanni Luca Ceresoli, Paolo Andrea Zucali, Letizia Gianoncelli, et al.
Cancer Management and Research|December 22, 2017
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness studyUmberto Restelli, Giovanni Luca Ceresoli, Davide Croce, et al.
Frontiers in Oncology|November 9, 2020
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional SurveyChiara Catania, Gianluca Spitaleri, Ester Del Signore, et al.
Lung Cancer (Auckland, N.Z.)|September 2, 2017
Clinical staging of malignant pleural mesothelioma: current perspectivesMaria Bonomi, Costantino De Filippis, Egesta Lopci, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesotheliomaGiovanni L Ceresoli, Paolo A Zucali, Fabio De Vincenzo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2014
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesotheliomaEgesta Lopci, Paolo Andrea Zucali, Giovanni Luca Ceresoli, et al.
Cancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Utility and Safety of Endosonography in the Diagnosis of Small Cell Lung Cancer: A Prospective Single-Center Observational StudyCarmine Salerni, Silvia Terraneo, Michele Bonanomi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|April 23, 2025
Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future OutlookGiovanni Luca Ceresoli, Letizia Gianoncelli
Annals of Translational Medicine|May 21, 2015
Prognostic and predictive value of MET deregulation in non-small cell lung cancerGiovanna Finocchiaro, Luca Toschi, Letizia Gianoncelli, et al.
Cancer Treatment Reviews|November 3, 2009
Second-line treatment for malignant pleural mesotheliomaGiovanni Luca Ceresoli, Paolo Andrea Zucali, Letizia Gianoncelli, et al.
Cancer Management and Research|December 22, 2017
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness studyUmberto Restelli, Giovanni Luca Ceresoli, Davide Croce, et al.
Frontiers in Oncology|November 9, 2020
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional SurveyChiara Catania, Gianluca Spitaleri, Ester Del Signore, et al.
Lung Cancer (Auckland, N.Z.)|September 2, 2017
Clinical staging of malignant pleural mesothelioma: current perspectivesMaria Bonomi, Costantino De Filippis, Egesta Lopci, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesotheliomaGiovanni L Ceresoli, Paolo A Zucali, Fabio De Vincenzo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2014
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesotheliomaEgesta Lopci, Paolo Andrea Zucali, Giovanni Luca Ceresoli, et al.
Cancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Utility and Safety of Endosonography in the Diagnosis of Small Cell Lung Cancer: A Prospective Single-Center Observational StudyCarmine Salerni, Silvia Terraneo, Michele Bonanomi, et al.
Pageof 2